A s bstract. The physiological relationship of increased circulating angiotensin II and vasopressin to circulatory changes during combined hypoxemia and hypercapnic acidosis is unclear. To evaluate the role(s) of angiotensin II and vasopressin, seven unanesthetized female mongrel dogs with controlled sodium intake (80 meq/24 h X 4 d) were studied during 40 min ofcombined acute hypoxemia and hypercapnic acidosis (PaO2, 36±1 mmHg; PaCO2, 55±2 mmHg; pH = 7.16±0.04) under the following conditions: (a) intact state with infusion of vehicles alone; (b) beta-adrenergic blockade with infusion of d,l-propranolol (1.0 mg/kg bolus, 0.5 mg/kg per h); (c) vasopressin pressor antagonism by the administration of the vasopressin pressor antagonist d-(CH2)5Tyr(methyl)arginine-vasopressin (10 pg/kg); and (d) simultaneous vasopressin pressor and angiotensin II inhibition with the additional infusion of I-sarcosine, 8-alanine angiotensin 11 (2.0 ,g/kg per min). The rise in mean arterial pressure during the combined blood-gas derangement with vehicles appeared to be related to increased cardiac output, since total peripheral resistance fell. Beta-adrenergic blockade abolished the fall in total peripheral resistance and diminished the rise in cardiac output during combined hypoxemia and hypercapnic acidosis, but the systemic pressor response was unchanged. In addition, the rise in mean arterial pressure during the Address reprint requests to Dr. Rose, Pulmonary Division, University of Virginia Medical Center.
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Introduction
Compensatory processes maintain circulatory function in healthy human subjects during acute hypoxemia (1, 2) , acute hypercapnic acidosis (3) , and combined hypoxemia and hypercapnic acidosis (4) . The maintenance of circulatory homeostasis also was evident in recent laboratory observations in unanesthetized dogs with increased mean arterial pressure during acute hypoxemia or acute hypercapnic acidosis (5) . In addition, the combination of acute hypoxemia and hypercapnic acidosis led to further increases in mean arterial pressure, but renal hemodynamic function decreased (5) . Despite the evidence of circulatory homeostasis during acute hypoxemia and/or hypercapnic acidosis from these clinical and laboratory experiments, the specific mechanisms for compensatory processes have not yet been elucidated.
The sympathetic nervous system has been heralded as having a major role in maintaining circulatory homeostasis during acute hypoxemia (6) and acute hypercapnic acidosis (7) , based on observations in anesthetized dogs. Evidence ofsympathetic nervous system activation is provided by recent observations of increased circulating catecholamines during acute hypoxemia and hypercapnic acidosis in unanesthetized dogs (8) . However, a central role for the sympathetic nervous system in circulatory homeostasis can be questioned in view of previous observations that the systemic vascular responses to exogenous catecholamines are diminished during acute hypoxemia (9) and hypercapnic acidosis (10) . Moreover, recent laboratory investigations in dogs reveal that other circulating pressor substances are increased during acute hypoxemia and hypercapnic acidosis and may contribute to systemic or renal vasoconstriction; these substances include angiotensin 11 (5) and vasopressin (1 1) .
We have previously demonstrated an important role for the renin-angiotensin system in cardiovascular regulation during combined hypoxemia and hypercapnic acidosis (5) . The present study was designed to investigate the effects of vasopressin blockade and simultaneous vasopressin and angiotensin II blockade during acute hypoxemia and hypercapnic acidosis in unanesthetized dogs. This was accomplished by the use ofspecific antagonists of the vascular effects of vasopressin and angiotensin II.
The present experiments suggest that the systemic pressor response during combined hypoxemia and hypercapnic acidosis is a balance ofmultiple effects ofthe sympathetic nervous system, angiotensin II, and vasopressin. When intact, angiotensin II and vasopressin limit the fall in total peripheral resistance during the combined blood-gas derangement, such that the rise in cardiac output mediated by the sympathetic nervous system predominates, and mean arterial pressure increases.
Methods
Animal preparation. Studies were performed in seven unanesthetized female mongrel dogs who weighed from 18.4 to 27.9 kg. During pentobarbital anesthesia (30 mg/kg, i.v.) each animal underwent preparatory surgery with sterile technique, which consisted of carotid artery exteriorization into a carotid loop, tracheostomy, and splenectomy, at least 4 wk before study. The splenectomy was performed to abolish any increase in hematocrit during the acute blood-gas derangements, as has been observed in anesthetized animals during hypercapnic acidosis ( 12) . All animals recovered completely and were not studied in any protocol for at least 4 wk. Before study, each animal was placed on a constant sodium intake of 80 meq/24 h for 4 
Protocols
Effects ofcombined acute hypoxemia and hypercapnic acidosis in conscious animals. The protocols were begun after 1 h of equilibration in the Pavlovian sling and after documentation of stable urine flow. Measurements were obtained over two consecutive 20-min control periods (0-40 min). This was followed by a 5-min intermediate period (40-45 min) in which either the vasopressin antagonist or vehicle was administered, and either the angiotensin antagonist infusion or vehicle was begun. The combined stimulus ofacute hypoxemia and acute hypercapnic acidosis was then induced for two consecutive 20-min periods (45-85 min). After measurements during combined hypoxemia and hypercapnic acidosis were completed, the degree of angiotensin II inhibition was assessed by the systemic pressor response to an intravenous injection of angiotensin I, 1,000 ng (Beckman Biochemicals, Palo Alto, CA). It has previously been shown that acute hypoxemia diminishes the activity of angiotensin I-converting enzyme in endothelial cell culture ( 13) . The systemic pressor response was determined with angiotensin I rather than angiotensin II to document an intact renin-angiotensin system after 40-min of the combined blood-gas derangement with vehicles alone. Postcontrol measurements were obtained during two 20-min periods 40 min after the cessation ofthe blood-gas derangement (125-165 min). After postcontrol measurements, the degree of vasopressin pressor blockade was assessed by the systemic pressor response to an intravenous injection ofarginine vasopressin, 20 mU/kg (Pitressin; Parke, Davis and Co., Morris Plains, NJ). Each dog served as its own control and was studied in the following four protocols, performed no more frequently than every 2 wk.
Protocol I: combined acute hypoxemia and hypercapnic acidosis during infusion of vehicles alone (n = 6). This protocol was performed to determine the effects of the combined stimulus in the presence of the angiotensin and vasopressin inhibitor vehicles. These control studies have, in part, been previously reported for five of the animals (5). After control measurements were made, an infusion ofthe angiotensin inhibitor vehicle (D5W) at 0.5 ml/min was instituted at the onset of the intermediate period and continued through the combined stimulus (40-85 min). In addition, the acetate/acetic acid vehicle for the vasopressin antagonist was injected as an intravenous bolus over 5 min during the intermediate period (40) (41) (42) (43) (44) (45) (14) . The degree of beta-adrenergic blockade was assessed by blockade of the increase in heart rate with an intravenous injection ofthe beta-agonist isoproterenol hydrochloride (Breon Laboratories, Inc., New York, NY), 0.1 g/kg after the last postcontrol period (165 min) was completed. Heart rate failed to rise significantly with injection of isoproterenol after the administration of propranolol (a change of 0±3 beats/min) and was significantly reduced (P < 0.0001) from the increase in heart rate of 135+±18 beats/min that had occurred with a comparable dose of isoproterenol during intact beta-adrenergic function.
Protocol Protocol IV: combined acute hypoxemia and hypercapnic acidosis during simultaneous vasopressin and angiotensin II inhibition (n = 6).
Previous investigators observed that renin-angiotensin system activation compensates for the effects of vasopressin blockade in water-deprived rats and that the fall in systemic arterial pressure with vasopressin blockade is accentuated when combined with angiotensin II blockade (16) . To prevent angiotensin II or vasopressin from masking the effects of inhibition of the alternate peptide, the angiotensin II and vasopressin inhibitors were administered simultaneously during combined hypoxemia and hypercapnic acidosis. The infusion of 1-sarcosine, 8 (Fig. 1) .
To determine if the combination of the angiotensin and vasopressin antagonists had nonspecific effects on systemic hemodynamic function, the protocol was precisely repeated, except that the animals breathed room air throughout the protocol (n = 5). The infusion of [Sar', Ala8]-AII at 2 pg/kg per min for from 40 to 85 min, and the injection of d-(CH2)5Tyr(Me)AVP at 10 ag/kg in acetate/acetic acid vehicle from 40 to 45 min were identical. The systemic pressor response to intravenous angiotensin I, 1,000 ng, was reduced (P < 0.01) to 0±4 mmHg, compared with 18±3 mmHg in the absence of angiotensin inhibition in protocol I. The systemic pressor response to intravenous arginine vasopressin, 20 mU/kg, was reduced (P < 0.01) to 1±2 mmHg, compared with 19±4 mmHg in the absence of vasopressin inhibition in protocol I.
Hemodynamic measurements and assays. Methods employed for hemodynamic measurements and assays have been described recently (5) . Briefly, arterial pressure was measured from the carotid artery catheter and central venous pressure was measured from the external jugular venous catheter with vascular transducers (1 280C; Hewlett-Packard Co., Instrument Products Group, Andover, MA) zeroed 5 cm dorsal to the sternum. Arterial pressure was measured at 2, 4, 6, 14, 16, and 18 min in each 20-min period. The measurements were averaged for two 20-min periods to obtain single values for control, combined blood-gas derangement, and postcontrol periods. In addition, changes in arterial pressure were assessed every 10 min in these periods by averaging early (2, 4, and 6 min) and late (14, (Table I ). In addition, systemic vascular resistance fell (P < 0.01) from a control value of 4,086±400 to 2,514±135 dynes* sec* cm-5 during the combined blood-gas derangement and increased (P < 0.05) reversibly to 3,279±224 dynes* sec* cm-5 in the postcontrol period. Stroke volume was unchanged, whereas an increase in heart rate was observed during the combined blood gas derangement with vehicles alone ( Table I) .
Effects of combined hypoxemia and hypercapnic acidosis during beta-adrenergic blockade. Mean arterial pressure increased from a control value of 1 19±5 to 136±5 mmHg during combined hypoxemia and hypercapnic acidosis and beta-adrenergic blockade, and fell reversibly to 116±5 mmHg in the postcontrol period (Fig. 3 ). This systemic pressor response was comparable to the increase in mean arterial pressure observed during the combined blood-gas derangement with vehicles alone (Table II) . In addition, chronological analysis of mean arterial pressure revealed that the systemic pressor response during the combined blood-gas derangement with propranolol in protocol II was identical to combined hypoxemia and hypercapnic acidosis with vehicles alone in protocol I (Fig. 4) . Cardiac output increased mildly during the combined blood-gas derangement with beta-adrenergic blockade (Table I ), but the rise in cardiac output was significantly less than during combined hypoxemia and hypercapnic acidosis with vehicles alone (Table II) . In addition, total peripheral resistance failed to decrease during the combined blood-gas derangement with propranolol (Table I ). An inspection of early and late changes in total peripheral resistance revealed responses during the combined blood-gas derangements identical during beta-adrenergic blockade and vehicles alone (Fig. 5) . Systemic vascular resistance was also unchanged from a control of 2,979±381 to 2,496±194
dynes. sec -cm-5 during the combined blood-gas derangement with propranolol. Heart rate increased during combined hypoxemia and hypercapnic acidosis with beta-adrenergic blockade (Table I) . Stroke volume fell in four of the five animals but was statistically unchanged compared with the control (Table I) . However, the change in stroke volume from control to the combined blood-gas derangement period with propranolol was significantly different from the increase observed during the com- bined blood-gas derangement with simultaneous vasopressin pressor and angiotensin II blockade in protocol IV (Table II) . (Fig. 3 ). This systemic pressor response was comparable (Table  II) sponses between the combined blood-gas derangement with vehicles alone in protocol I and with d-(CH2)5Tyr(Me)AVP in protocol III (Fig. 4) . Cardiac output increased and total peripheral resistance decreased during combined hypoxemia and hypercapnic acidosis with d-(CH2)5Tyr(Me)AVP (Table I) ; the overall changes in these variables were comparable to the combined blood-gas derangement with vehicles alone in protocol I (Table  II) . Systemic vascular resistance also decreased (P < 0.01) from a control value of 3,026±434 to 1,743±128 dynes. seccm-5 during the combined blood-gas derangement with d-(CH2)5Tyr(Me)AVP. However, compared with the combined blood-gas derangement with vehicles alone in protocol I or with beta-adrenergic blockade in protocol II, total peripheral resistance was diminished during the last 30 min ofcombined hypoxemia and hypercapnic acidosis with d4CH2)5Tyr(Me)AVP in protocol III (Fig. 5) . Heart rate increased reversibly during the combined blood gas derangement with vasopressin blockade (Table I ), but stroke volume was unchanged. The change in heart rate and stroke volume was comparable to combined hypoxemia and hypercapnic acidosis with vehicles alone in protocol I (Table II) (Table III) were both unchanged with the administration of d-(CH2)5Tyr(Me)AVP during normal gas exchange. Although both cardiac output and (Table III) . In addition, stroke volume was unchanged with the administration of the vasopressin pressor antagonist (Table III) .
Combined hypoxemia and hypercapnic acidosis with simultaneous vasopressin and angiotensin II blockade. Mean arterial pressure was comparable during the control periods between combined blood-gas derangement protocols with vehicles alone, beta-adrenergic blockade, and vasopressin and angiotensin II inhibition (Fig. 3) . In contrast to all other combined bloodgas derangement protocols, the average systemic pressor response during the combined blood-gas derangement with simultaneous vasopressin and angiotensin II blockade was abolished. This was reflected in unchanged mean arterial pressure from a control value of 108±5 to 111±6 mmHg during combined hypoxemia and hypercapnic acidosis with both inhibitors (Fig. 3) . Moreover, the change in mean arterial pressure from control to the combined blood-gas derangement periods during simultaneous vasopressin and angiotensin II blockade was significantly different (P < 0.05) from the response during the combined blood-gas derangement with vehicles alone in protocol I, in contrast to responses during the combined blood-gas derangement with beta-adrenergic blockade in protocol II or vasopressin blockade alone in protocol III (Table II) . Chronological analysis of the systemic pressor response revealed that the early rise in mean arterial pressure in the first 10 min of the combined blood-gas derangement with vehicles alone was present during combined hypoxemia and hypercapnic acidosis with simultaneous vasopressin and angiotensin II inhibition in protocol IV (Fig. 4) . However, mean arterial pressure subsequently fell progressively during the ensuing 30 min of the combined blood-gas derangement with both inhibitors and was significantly diminished from the combined blood-gas derangement with vehicles alone (Fig. 4) .
Cardiac output increased and total peripheral resistance fell during the combined blood-gas derangement with simultaneous administration of both inhibitors (Table I ). In addition, cardiac output and total peripheral resistance remained elevated and decreased, respectively, in the postcontrol period, compared with control. The overall changes in cardiac output and total peripheral resistance were comparable to combined hypoxemia and hypercapnic acidosis with vehicles alone in protocol I (Table  II) . Systemic vascular resistance also decreased (P < 0.01) from a control value of 3,715±706 to 1,655±164 dynes*sec-cm-5 during the combined blood-gas derangement with both inhibitors. Total peripheral resistance fell in parallel with mean arterial pressure during the latter 30 min of combined hypoxemia and hypercapnic acidosis with angiotensin II and vasopressin pressor inhibition, and was diminished compared with the combined blood-gas derangement with vehicles alone in protocol I or with beta-adrenergic inhibition in protocol II (Fig. 5) . Both heart rate and stroke volume increased during the combined blood-gas derangement with both inhibitors (Table I) . However, the change in heart rate and stroke volume during the combined blood gas derangement with vasopressin and angiotensin II inhibition was comparable to combined hypoxemia and hypercapnic acidosis with vehicles alone in protocol I (Table II) .
Effects ofd-(CH2)5Tyr(Me)A VP and [Sar', Ala8]-AII alone. Both PaO2 and PaCO2 were unchanged from control values of 100±7 and 29±8 mmHg, respectively, with the administration of vasopressin pressor and angiotensin II antagonists while the animals breathed room air. In addition, arterial blood pH and minute ventilation were unchanged from control of 7.37±0.01 and 4.2±0.7 liters/min.
Mean arterial pressure, cardiac output, total peripheral resistance, and heart rate (Table III) were unchanged with combined administration of d-(CH2)5Tyr(Me)AVP and [Sar', Ala8]-All, but total peripheral resistance fell and heart rate increased in the postcontrol period. Stroke volume was unchanged with administration of the vasopressin pressor and angiotensin II antagonists.
Changes in plasma renin activity and circulating vasopressin and catecholamines. Plasma renin activity increased comparably during the combined blood gas derangement with vehicles alone, d,l-propranolol, d-(CH2)5Tyr(Me)AVP, and simultaneous vasopressin pressor and angiotensin II blockade (Fig. 6 ). In addition, the rise in plasma renin activity from control to combined hypoxemia and hypercapnic acidosis with beta-adrenergic inhibition and vasopressin pressor and angiotensin II blockade was comparable to the combined blood-gas derangement with vehicles alone.
Plasma arginine vasopressin concentrations increased (P < 0.01) substantially from a control value of 1 
Control
Combined Post-Control Hypox + HC Figure 6 . The rise in plasma renin activity during combined hypoxemia and hypercapnic acidosis (Hypox + HC) with d,l-propranolol (o) (n = 5), or vasopressin and angiotensin II blockade (n) (n = 6) was comparable to the combined blood-gas derangement with vehicles alone (o) (n = 6). rm, vasopressin pressor blockade alone. *P < 0.05, **P < 0.01; both comparison with protocol control period. pg/ml during combined hypoxemia and hypercapnic acidosis with vehicles alone and were 1.7±0.6 pg/ml in the postcontrol period.
Circulating norepinephrine was unchanged during combined hypoxemia and hypercapnic acidosis with vehicles alone but increased profoundly during the combined blood-gas derangement with combined vasopressin pressor and angiotensin II blockade (Table IV) . Plasma norepinephrine concentrations were elevated comparably during the first and second 20-min periods ofthe combined blood-gas derangement with vasopressin pressor and angiotensin II blockade in protocol IV. Moreover, the change in plasma norepinephrine concentrations from control to combined hypoxemia and hypercapnic acidosis with simultaneous vasopressin pressor and angiotensin II inhibition in protocol IV exceeded (P < 0.025) the response during the combined bloodgas derangement with vehicles alone in protocol I. Circulating epinephrine was unchanged during the combined blood gas derangement with vehicles alone (Table IV) . Although plasma epinephrine concentrations increased in all six dogs during the combined blood-gas derangement with both inhibitors in protocol IV, the change was not statistically significant, probably because of a hyper-response in one dog. Plasma dopamine concentrations were unchanged during the combined blood-gas derangement with vehicles alone but increased during combined hypoxemia and hypercapnic acidosis with both inhibitors (Table IV) .
Discussion
The present study demonstrates that vasopressin and angiotensin II are important contributors to the systemic pressor response during combined hypoxemia and hypercapnic acidosis. This was reflected by a progressive fall in mean arterial pressure and total peripheral resistance during the combined blood-gas derangement with simultaneous vasopressin pressor and angiotensin II inhibition. It is unlikely that the systemic pressor response during combined hypoxemia and hypercapnic acidosis depends solely upon increased cardiac output. The rise in mean arterial pressure during the combined blood-gas derangement in the face of decreased total peripheral resistance suggests a central role for increased cardiac output. However, a comparable rise in mean arterial pressure occurred during combined hypoxemia and hypercapnic acidosis with beta-adrenergic blockade, with a reduced rise in cardiac output and an unchanged total peripheral resistance. Moreover, mean arterial pressure was unchanged during the combined blood-gas derangement with simultaneous vasopressin pressor and angiotensin II inhibition when cardiac output was elevated and total peripheral resistance was further diminished. These data suggest that changes in both flow and resistance in the systemic circulation are important factors in the systemic pressor response during the combined blood-gas derangement. The increase in cardiac output during combined hypoxemia and hypercapnic acidosis appears to be mediated largely by the beta-adrenergic system. The concomitant fall in total peripheral resistance is probably the summation of the effects of multiple factors, including the beta-adrenergic system, vasopressin, and angiotensin II. Although the present study does not identify all the factors responsible for the control of total peripheral resistance during the combined blood-gas derangement, it is clear that vasopressin and angiotensin II are important contributors to the rise in mean arterial pressure by limiting the fall in total peripheral resistance so that the rise in cardiac output predominates.
Although recent studies have identified an important role for vasopressin during dehydration (16, 23) and nonhypotensive hemorrhage (24) , the physiological significance of increased circulating vasopressin during acute hypoxemia and hypercapnic acidosis (1 1, 12, 19) has not been evaluated.
The present study was undertaken to evaluate the role of vasopressin during combined hypoxemia and hypercapnic acidosis by the administration of d-(CH2)5Tyr(Me)AVP, a recently developed antagonist of the vasoconstrictive effects of arginine vasopressin (15) . The efficacy of this antagonist in the present study is demonstrated by inhibition of the systemic pressor response to arginine vasopressin, confirming previous observations in anesthetized rats (15) . Although total peripheral resistance was diminished compared with combined hypoxemia and hypercapnic acidosis with vehicles alone, the rise in mean arterial pressure was unaltered during the combined blood-gas derangement with vasopressin pressor antagonism alone, probably because ofactivation ofthe renin-angiotensin system. The absence ofaugmentation in plasma renin activity with vasopressin pressor antagonism contrasts with an accentuated rise in plasma renin activity in conscious dogs with administration of vasopressin pressor inhibitors during nonhypotensive hemorrhage (24) and water deprivation (23) . The lack of enhancement in the rise in plasma renin activity during the combined blood-gas derangement with vasopressin pressor blockade may account for the pronounced fall in total peripheral resistance comparable to combined hypoxemia and hypercapnic acidosis with vasopressin pressor and angiotensin II inhibition. The reasons for the lack ofaugmentation in plasma renin activity with vasopressin pressor inhibition are unclear.
We have recently observed that angiotensin II inhibition alone also failed to alter the rise in mean arterial pressure and the decrease in total peripheral resistance during combined hypoxemia and hypercapnic acidosis in conscious dogs (5) . However, inhibition of angiotensin II during the combined bloodgas derangement resulted in diminished renal hemodynamic function (5 (25) . Thus, inadequate angiotensin inhibition in the previous study is unlikely. Decreased responsiveness to angiotensin I seems unlikely in view of the systemic pressor response to angiotensin I during the combined bloodgas derangement in the present study.
The findings of the present study are most consistent with the possibility that enhanced secretion of vasopressin offsets the effects of angiotensin II inhibition during the combined stimulus. This enhanced secretion of vasopressin with functional ablation of the renin-angiotensin system has been observed previously with hypotensive hemorrhage in anesthetized dogs (26) . In support of this possibility, when angiotensin II and vasopressin blockade were imposed simultaneously during combined hypoxemia and hypercapnic acidosis in the present study, mean arterial pressure and total peripheral resistance fell progressively after the unaltered rise in mean arterial pressure in the first 10 min.
Taken together, the present experiments clearly demonstrate important roles for angiotensin II and vasopressin in the systemic pressor response during combined hypoxemia and hypercapnic acidosis.
The interaction between angiotensin II and vasopressin in the present study is indicated by the independent ability of each system to support the rise in mean arterial pressure when either system is functionally inactivated. The existence of dual mechanisms involving angiotensin II and vasopressin for the maintenance of circulatory homeostasis has been described previously during water deprivation in the anesthetized rat (16) and after autonomic blockade in the anesthetized dog (27) . However, other forms of vasopressin/angiotensin II interaction, such as angiotensin II-induced vasopressin release (28) and vasopressin inhibition of renin secretion (29), are not evident in the present observations.
The beta-adrenergic component ofthe sympathetic nervous system also plays an important role in the systemic pressor response during combined hypoxemia and hypercapnic acidosis, through increased cardiac output. In addition, an early rise in the first 10 Beta-adrenergic blockade probably limited the increase in cardiac output during the combined blood-gas derangement through decreased stroke volume, since the tachycardic response was unaltered. Although stroke volume fell in four of five dogs from control to combined hypoxemia and hypercapnic acidosis with propranolol, the change was not significant. However, the fall in stroke volume from control to the combined blood-gas derangement with propranolol was significantly different from the increase in stroke volume during combined hypoxemia and hypercapnic acidosis with both inhibitors. The failure of betaadrenergic blockade to abolish the tachycardia during the combined blood-gas derangement indicates neither absence of involvement of the sympathetic nervous system nor inadequate blockade. In sympathectomized conscious dogs with 6-hydroxydopamine and adrenalectomy, Hammill and colleagues (30) observed tachycardia during acute hypoxemia, secondary to diminished parasympathetic tone. In intact animals, parasympathetic blockade alone with atropine failed to expunge the tachycardia of acute hypoxemia. However, when parasympathetic blockade was added to interruption of the sympathetic nervous system, the tachycardia of acute hypoxemia was abolished. Although the stimulus of hypoxemia alone in this previous study differs from the combined blood-gas derangement in the present study, the mechanism oftachycardia may be comparable.
Unchanged circulating catecholamines during combined hypoxemia and hypercapnic acidosis with vehicles alone does not exclude a role for the beta-adrenergic system on the rise in cardiac output and heart rate and decrease in total peripheral resistance in the present study. Changes in circulating catecholamines are a rough index of activation of the sympathetic nervous system and may incorrectly reflect the state of activation of the sympathetic nervous system, especially in neurally mediated events. We have previously observed increased circulating catecholamines in conscious dogs during combined hypoxemia and hypercapnic acidosis (8) . However, the combined bloodgas derangement in which circulating catecholamines rose was always preceded by 80 min of either acute hypoxemia alone or acute hypercapnic acidosis alone. This difference in the present study may account for unchanged circulating catecholamines.
The sustained rise in circulating catecholamines during the second 20 min ofthe combined stimulus with parallel inhibition of angiotensin II and vasopressin is strong evidence against diminished activity of the sympathetic nervous system. Increased beta-adrenergic stimulation may have contributed to the progressive fall in total peripheral resistance in the latter 30 min of the combined blood-gas derangement with both inhibitors.
In summary, the present experiments demonstrate an important role for vasopressin and angiotensin II in the rise in mean arterial pressure during combined hypoxemia and hypercapnic acidosis in conscious dogs through maintenance of total peripheral resistance, so that the beta-adrenergically mediated increase in cardiac output predominates. When the actions of both hormones were inhibited, mean arterial pressure fell after an initial rise in the first 10 min of the combined bloodgas derangement. These studies suggest important physiological roles for vasopressin and angiotensin II in healthy human subjects and patients during hypoxemia and hypercapnic acidosis.
